Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Breaking Down The Use of Rina-S in Advanced Ovarian Cancer

April 16th 2025, 8:00pm

Video

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

BELLA Clinical Trial Initiated in Platinum-Resistant Ovarian Cancer

April 7th 2025, 3:00pm

Article

The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ovarian cancer has been launched.

Development of Nemvaleukin for Platinum-Resistant Ovarian Cancer Halted

April 3rd 2025, 1:00pm

Article

A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on to final analysis.

Relacorilant Plus Chemo Meets Primary Goal in Ovarian Cancer Trial

March 31st 2025, 3:29pm

Article

The phase 3 trial showed relacorilant with chemotherapy improved progression-free and overall survival in platinum-resistant ovarian cancer.

Rina-S Generates Antitumor Activity in Heavily Pretreated Ovarian Cancer

March 27th 2025, 1:00pm

Video

Treatment with Rina-S showed antitumor activity in heavily pretreated patients with advanced ovarian cancer, according to the phase 2 RAINFOL-01 study.

First Patient Dosed in Phase 3 Trial of IBI354 for Ovarian Cancer

March 24th 2025, 7:00pm

Article

The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.

Phase 3 Study Design Finalized with FDA for IMNN-001 in Ovarian Cancer

March 24th 2025, 3:00pm

Article

The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory agencies.

Elahere Shows Consistent Survival Benefit in Ovarian Cancer Subset

March 17th 2025, 9:00pm

Article

Elahere shows consistent survival benefits in patients with folate receptor alpha-positive platinum-resistant ovarian cancer in the MIRASOL trial.

Ovarian Cancer Teaches Hard Life Lessons

January 29th 2025, 6:00pm

Article

Having a life-threatening disease reminds me daily to make the most of whatever time I have.

HIPEC May Not Improve Outcomes for Recurrent Epithelial Ovarian Cancer

January 13th 2025, 4:00pm

Article

Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer.